Chicago, IL, United States of America

Nicholas L Angeloni

This inventor holds 1 USPTO granted patent. Top assignee: Northwestern University. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Nicholas L Angeloni in Nanostructures

Introduction

Nicholas L Angeloni is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of nanotechnology, particularly in the modulation of intercellular communication. His work focuses on developing innovative solutions for various medical conditions.

Latest Patents

Angeloni holds a patent for "Nanostructures for modulating intercellular communication and uses thereof." This patent encompasses nanostructures, compositions, and methods aimed at treating vesicle-related or exosome-related conditions. The applications of his invention include potential treatments for cancers, neurological disorders, rheumatologic disorders, viral disorders, and other diseases. His research emphasizes the regulation of vesicle uptake, along with methods for analyzing, imaging, and modulating vesicle processes.

Career Highlights

Nicholas L Angeloni is affiliated with Northwestern University, where he continues to advance his research in nanotechnology. His work has garnered attention for its potential impact on medical treatments and therapies.

Collaborations

Angeloni collaborates with notable colleagues, including Michael P Plebanek and C Shad Thaxton. Their combined expertise enhances the research and development of innovative solutions in their field.

Conclusion

Nicholas L Angeloni's contributions to nanotechnology and intercellular communication represent a significant advancement in medical science. His innovative patent and ongoing research hold promise for addressing critical health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…